Skip to Main Content
Accessibility Overview
JOIN A MEETING
HOST A MEETING
With Video Off
With Video On
HOST A MEETING WITH VIDEO
HOST A MEETING WITHOUT VIDEO
Sign In
Sign Up Free
webinar register page
This webinar is for internal users only.
Topic
EWIS & AMS PhD Career Panel. Where will you PhD take you?
Description
EWIS (Empowering Women in Science) and AMS (Association of Multicultural Scientist) are co-hosting the PhD Career Panel. Where will you PhD take you?. This panel is for graduate students and undergraduates interested in STEM. EWIS and AMS would like to offer opinions of professionals in the STEM field in academia, industry and government to give you a big picture of what to do with your PhD.
HYBRID EVENT:
ZOOM: personal-unique link will be provided after registration on confirmation email.
IN-PERSON:
@Microbiology Research Facility (MRF) room 1-101
689 23rd Ave SE, Minneapolis, MN 55455. https://goo.gl/maps/gE827xzHd3PngoAv7
NEAREST PUBLIC PARKING FACILITIES: Victory Lot, Maroon Lot & Gopher Lot.
SUBMIT QUESTIONS FOR PANELIST & IF YOU ARE ATTENDING IN-PERSON SELECT YOU LUNCH OPTION: https://forms.gle/LJvTEtukpfUhWuyBA
This link also will be provided after registration in the confirmation email.
Time
Nov 14, 2022 12:00 PM in
Central Time (US and Canada)
Webinar is over, you cannot register now. If you have any questions, please contact Webinar host:
EWIS & AMS
.
×
Share via Email
All fields are required
Your Information
Send to
Message preview
Hi there, You are invited to a Zoom webinar. When: Nov 14, 2022 12:00 PM Central Time (US and Canada) Topic: EWIS & AMS PhD Career Panel. Where will you PhD take you? Register in advance for this webinar: https://umn-private.zoom.us/webinar/register/WN_N9PB4YUbQF6tWGz_z6LOfA Or an H.323/SIP room system: H.323: 162.255.37.11 (US West) 162.255.36.11 (US East) 221.122.88.195 (China) 115.114.131.7 (India Mumbai) 115.114.115.7 (India Hyderabad) 213.19.144.110 (Amsterdam Netherlands) 213.244.140.110 (Germany) 103.122.166.55 (Australia Sydney) 103.122.167.55 (Australia Melbourne) 209.9.211.110 (Hong Kong SAR) 64.211.144.160 (Brazil) 69.174.57.160 (Canada Toronto) 65.39.152.160 (Canada Vancouver) 207.226.132.110 (Japan Tokyo) 149.137.24.110 (Japan Osaka) Meeting ID: 960 6322 5643 SIP: 96063225643@zoomcrc.com After registering, you will receive a confirmation email containing information about joining the webinar. ---------- Webinar Speakers Dr Deepali Malhotra (Associate Director in Cell Therapy (Oncology R&D) @AstraZeneca) Dr Deepali Malhotra did her undergraduate and graduate studies at Harvard University and her Post-doctoral research at the University of Minnesota Center for Immunology. She is a scientist who has studied diverse areas of immunology, ranging from how self-reactive CD4+ T cells are kept from wreaking havoc in the body to how long-overlooked lymph node stromal cell populations regulate and contribute to adaptive immunity. A unifying theme in her work is the quest to understand the rules that govern how the adaptive immune system interacts with the body, with the ultimate goal of using this knowledge to develop therapies or interventions. As an immunologist with significant expertise in stromal and T cell immunity and mechanisms of self-tolerance, her professional interests lie in the treatment of autoimmune diseases, immuno-oncological interventions, adoptive cell therapies, and T cell mediated vaccine development. Dr Kristina Burrack (Principal Investigator @Hennepin Healthcare Research Institute) Dr Kristina Burrack earned her doctoral degree in 2014 from the University of Colorado School of Medicine, in the Department of Immunology. She completed her postdoctoral training at the University of Minnesota, Department of Laboratory Medicine and Pathology, in the laboratory of Stephen C. Jameson, Ph.D. Dr. Burrack joined Hennepin Healthcare Research Institute in 2018. Dr Burrack's laboratory combines translational research and animal models of Plasmodium infection to investigate the immune response to malaria. Her goal is to develop a comprehensive understanding of host-pathogen interactions in order to enhance immunity and limit immune-mediated pathology with an emphasis on investigating the pathogenesis of malaria and other pathogens of global health importance. Dr Meggan Craft (Associate Professor Ecology, Evolution and Behavior @University of Minnesota) Dr Meggan Craft is an infectious disease ecologist. The broad aim of her research program is to understand infectious disease dynamics in animal and human populations. She tests hypotheses regarding disease spread and consequent control through parameterizing theoretical disease models with empirical data. She is interested in two fundamental areas: (i) How are pathogens maintained in multi-host ecosystems? (ii) How does heterogeneity in population contact structure affect pathogen dynamics? She has a friendly and welcoming lab. Her lab is inherently interdisciplinary as they work at the intersection of environmental, human, and animal health. Current research projects in the Craft lab focus on modeling: swine viruses (e.g. influenza and FMD), bovine tuberculosis in cattle, “large cat” retroviruses (i.e., feline immunodefiency virus in pumas and African lions), and coyote pathogens. Dr Pam Rosato (Assistant Professor of Microbiology and Immunology @Dartmouth Geisel School of Medicine) Dr Pam Rosato Pam grew up in Massachusetts and received her B.S. from The College of William & Mary in 2008. There, her time in the lab of Dr. Patty Zwollo studying B cells in rainbow trout sparked her interest in immunology. She then spent a year at the Ragon Institute in Boston as a technician before joining the Molecular & Cellular Biology graduate program at Dartmouth. Pam earned her Ph.D. from the lab of Dr. David Leib where she studied neuronal immunity to herpes simplex virus. She trained as postdoc with Dr. David Masopust at the University of Minnesota and returned to Dartmouth as an Assistant Professor in 2020. Her lab is interested in understanding the function and regulation of TRM in distinct tissue environments to be able to contextualize their role in cancer, infection and autoimmunity. Her current focuses: TRM in the brain, TRM as a brain tumor immunotherapy and TRM and oncolytic viral therapy. Dr David Largaespada (Professor, Dept of Pediatrics. Assoc. Director for Basic Sciences, MCC. Director, Brain Tumor Prog, MCC @University of Minnesota) Dr David Largaespada is a full professor in the Departments of Pediatrics and Genetics, Cell Biology, and Development and the Associate Director for Basic Research in the Masonic Cancer Center at University of Minnesota. He is an authority on mouse genetics, gene modification, and cancer genes. He received his BS in Genetics and Cell Biology from the University of Minnesota, Twin Cities in 1987 and his PhD in Molecular Biology with Dr. Rex Risser at the University of Wisconsin-Madison in 1992. He did a post-doctoral fellowship at the National Cancer Institute working with world-renowned geneticists Dr. Nancy Jenkins and Dr. Neal Copeland, where the Leukemia and Lymphoma Society of America awarded him a post-doctoral fellowship. He joined the faculty of the University of Minnesota in late 1996. Dr. Largaespada currently holds the Hedberg Family/Children’s Cancer Research Fund Chair in Brain Tumor Research. He was awarded the American Cancer Society Research Professor Award in 2013. Dr Leigh Allen (Program Officer, Contraception Research Branch @NICHD (NIH)) Leigh Allen, Ph.D., became a program officer with CRB in 2022. Prior to joining NICHD, Dr. Allen spent 6 years at UMN in the Department of Medicinal Chemistry. She was the research program manager for a portfolio of 15+ different contraception-related projects and the administrative core of a Contraception Development Research Center grant (U54/P50). She also managed the submission of $125+ M in grants/contracts, served on PACC for the U’s P&A Senate and handled operations for the department and its affiliated Institute for Therapeutics Discovery & Development. Dr. Allen earned her Ph.D. in chemistry from Duke University, then performed postdoctoral studies in structural biology at both Hauptman-Woodward Institute and North Carolina State University. Her primary focus was the study of the mechanisms underpinning antibiotic resistance and bacterial biofilms. During this time, she also was a contract scientific editor for journal articles covering nearly all fields of science.
×
Switch Time Zone
Time Zone:
(GMT-11:00) Midway Island, Samoa
(GMT-11:00) Pago Pago
(GMT-10:00) Hawaii
(GMT-8:00) Alaska
(GMT-8:00) Juneau
(GMT-7:00) Vancouver
(GMT-7:00) Pacific Time (US and Canada)
(GMT-7:00) Tijuana
(GMT-7:00) Arizona
(GMT-7:00) Mazatlan
(GMT-7:00) Yukon
(GMT-6:00) Edmonton
(GMT-6:00) Mountain Time (US and Canada)
(GMT-6:00) Saskatchewan
(GMT-6:00) Mexico City
(GMT-6:00) Guatemala
(GMT-6:00) El Salvador
(GMT-6:00) Managua
(GMT-6:00) Costa Rica
(GMT-6:00) Tegucigalpa
(GMT-6:00) Chihuahua
(GMT-6:00) Monterrey
(GMT-5:00) Winnipeg
(GMT-5:00) Central Time (US and Canada)
(GMT-5:00) Panama
(GMT-5:00) Bogota
(GMT-5:00) Lima
(GMT-5:00) Acre
(GMT-4:00) Montreal
(GMT-4:00) Eastern Time (US and Canada)
(GMT-4:00) Indiana (East)
(GMT-4:00) Puerto Rico
(GMT-4:00) Caracas
(GMT-4:00) La Paz
(GMT-4:00) Guyana
(GMT-3:00) Halifax
(GMT-3:00) Santiago
(GMT-3:00) Montevideo
(GMT-3:00) Recife
(GMT-3:00) Buenos Aires, Georgetown
(GMT-3:00) Greenland
(GMT-3:00) Sao Paulo
(GMT-3:00) Atlantic Time (Canada)
(GMT-2:30) Newfoundland and Labrador
(GMT-2:00) Fernando de Noronha
(GMT-1:00) Azores
(GMT-1:00) Cape Verde Islands
(GMT+0:00) Universal Time UTC
(GMT+0:00) Greenwich Mean Time
(GMT+0:00) Reykjavik
(GMT+0:00) Dublin
(GMT+0:00) London
(GMT+0:00) Lisbon
(GMT+0:00) Casablanca
(GMT+0:00) Nouakchott
(GMT+1:00) Belgrade, Bratislava, Ljubljana
(GMT+1:00) Sarajevo, Skopje, Zagreb
(GMT+1:00) Oslo
(GMT+1:00) Copenhagen
(GMT+1:00) Brussels
(GMT+1:00) Amsterdam, Berlin, Rome, Stockholm, Vienna
(GMT+1:00) Amsterdam
(GMT+1:00) Rome
(GMT+1:00) Stockholm
(GMT+1:00) Vienna
(GMT+1:00) Luxembourg
(GMT+1:00) Paris
(GMT+1:00) Zurich
(GMT+1:00) Madrid
(GMT+1:00) West Central Africa
(GMT+1:00) Algiers
(GMT+1:00) Tunis
(GMT+1:00) Warsaw
(GMT+1:00) Prague Bratislava
(GMT+1:00) Budapest
(GMT+2:00) Helsinki
(GMT+2:00) Harare, Pretoria
(GMT+2:00) Sofia
(GMT+2:00) Athens
(GMT+2:00) Bucharest
(GMT+2:00) Nicosia
(GMT+2:00) Beirut
(GMT+2:00) Jerusalem
(GMT+2:00) Tripoli
(GMT+2:00) Cairo
(GMT+2:00) Johannesburg
(GMT+2:00) Khartoum
(GMT+2:00) Kyiv
(GMT+2:00) Chisinau
(GMT+3:00) Nairobi
(GMT+3:00) Istanbul
(GMT+3:00) Damascus
(GMT+3:00) Amman
(GMT+3:00) Moscow
(GMT+3:00) Baghdad
(GMT+3:00) Kuwait
(GMT+3:00) Riyadh
(GMT+3:00) Bahrain
(GMT+3:00) Qatar
(GMT+3:00) Aden
(GMT+3:00) Djibouti
(GMT+3:00) Mogadishu
(GMT+3:00) Minsk
(GMT+3:30) Tehran
(GMT+4:00) Dubai
(GMT+4:00) Muscat
(GMT+4:00) Baku, Tbilisi, Yerevan
(GMT+4:30) Kabul
(GMT+5:00) Yekaterinburg
(GMT+5:00) Islamabad, Karachi, Tashkent
(GMT+5:30) India
(GMT+5:30) Mumbai, Kolkata, New Delhi
(GMT+5:30) Colombo
(GMT+5:45) Kathmandu
(GMT+6:00) Almaty
(GMT+6:00) Dacca
(GMT+6:00) Astana, Dhaka
(GMT+6:30) Rangoon
(GMT+7:00) Novosibirsk
(GMT+7:00) Krasnoyarsk
(GMT+7:00) Bangkok
(GMT+7:00) Vietnam
(GMT+7:00) Jakarta
(GMT+8:00) Irkutsk, Ulaanbaatar
(GMT+8:00) Beijing, Shanghai
(GMT+8:00) Hong Kong SAR
(GMT+8:00) Taipei
(GMT+8:00) Kuala Lumpur
(GMT+8:00) Singapore
(GMT+8:00) Perth
(GMT+9:00) Yakutsk
(GMT+9:00) Seoul
(GMT+9:00) Osaka, Sapporo, Tokyo
(GMT+9:30) Darwin
(GMT+10:00) Vladivostok
(GMT+10:00) Guam, Port Moresby
(GMT+10:00) Brisbane
(GMT+10:30) Adelaide
(GMT+11:00) Canberra, Melbourne, Sydney
(GMT+11:00) Hobart
(GMT+11:00) Magadan
(GMT+11:00) Solomon Islands
(GMT+11:00) New Caledonia
(GMT+11:00) Lord Howe IsIand
(GMT+12:00) Kamchatka
(GMT+12:00) Fiji Islands, Marshall Islands
(GMT+13:00) Auckland, Wellington
(GMT+13:00) Independent State of Samoa
×
Continue to PayPal
Click to Continue
×